Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Immunoblastic Lymphadenopathy × temsirolimus × Clear all

Sponsor

Conditions

Carcinoma, Renal Cell 11 Sarcoma 6 Neoplasms 5 Rhabdomyosarcoma 4 Lymphoma, Mantle-Cell 4 Kidney Neoplasms 4 Osteosarcoma 3 Neoplasm Metastasis 3 Melanoma 3 Endometrial Neoplasms 3 Breast Neoplasms 3 Waldenstrom Macroglobulinemia 2 Prostatic Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Ovarian Neoplasms 2 Neuroectodermal Tumors, Primitive, Peripheral 2 Neuroblastoma 2 Lymphoma, Non-Hodgkin 2 Lymphoma, Follicular 2 Lymphoma, B-Cell, Marginal Zone 2 Liposarcoma 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Leukemia 2 Gliosarcoma 2 Glioblastoma 2 Fallopian Tube Neoplasms 2 Carcinoma, Hepatocellular 2 Brain Neoplasms 2 Uterine Cervical Neoplasms 1 Urogenital Neoplasms 1

Interventions

fludarabine phosphate 14 Cyclophosphamide 13 Whole-Body Irradiation 11 Peripheral Blood Stem Cell Transplantation 11 Etoposide 10 Tacrolimus 9 Mycophenolic Acid 7 Rituximab 6 Methotrexate 6 Melphalan 6 Cyclosporine 6 Busulfan 6 Antilymphocyte Serum 6 Vorinostat 4 Sirolimus 4 Prednisone 4 Lenalidomide 4 Immunohistochemistry 4 Gene Expression Profiling 4 Carboplatin 4 Vincristine 3 Microarray Analysis 3 Everolimus 3 Doxorubicin 3 Dexamethasone 3 Alemtuzumab 3 thymoglobulin 2 prednylidene 2 fludarabine 2 etoposide phosphate 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡